Dysregulated lipid metabolism blunts the sensitivity of cancer cells to EZH2 inhibitor.
Zhang T, Guo Z, Huo X, Gong Y, Li C, Huang J, Wang Y, Feng H, Ma X, Jiang C, Yin Q, Xue L.
Zhang T, et al. Among authors: gong y.
EBioMedicine. 2022 Mar;77:103872. doi: 10.1016/j.ebiom.2022.103872. Epub 2022 Feb 12.
EBioMedicine. 2022.
PMID: 35158113
Free PMC article.